Clinical Trials Browser

Phase 3 × Hematologic Neoplasms × Heparin × Clear all

NCT01820962 2013-03-29

Concentrated Citrate Locking to Reduce the Incidence of CVC-related Complications in Hematological Patients

Phase 3 Terminated

Other hematologic neoplasm

Thrombosis, Bacteremia, Hematologic Neoplasms, Catheter-Related Infections